Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000950123-11-010830
Filing Date
2011-02-09
Accepted
2011-02-09 11:53:36
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A v58578sc13gza.htm SC 13G/A 35868
  Complete submission text file 0000950123-11-010830.txt   37799
Mailing Address 11726 SAN VICENTE BOULEVARD SUITE 650 LOS ANGELES CA 90049
Business Address 11726 SAN VICENTE BOULEVARD SUITE 650 LOS ANGELES CA 90049 310-826-5648
CYTRX CORP (Filed by) CIK: 0000799698 (see all company filings)

EIN.: 581642750 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 60 PRESCOTT STREET WORCESTER MA 01605
Business Address 60 PRESCOTT STREET WORCESTER MA 01605 508-767-3861
RXI PHARMACEUTICALS CORP (Subject) CIK: 0001390478 (see all company filings)

EIN.: 000000000
Type: SC 13G/A | Act: 34 | File No.: 005-84090 | Film No.: 11585511
SIC: 2834 Pharmaceutical Preparations